insilTox ApS: Financial statements 2019
CVR: 36996641
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
insilTox ApS (CVR 36996641) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 199,410 and a net result of DKK -37,668 compared with DKK 5,167 the year before. That is an increase of 62.3% compared with the year before. Equity in the 2019 report amounted to DKK 28,923. The solvency ratio was 32.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 199,410
- Profit/Loss
- DKK -37,668
- Equity
- DKK 28,923
- Total Assets
- DKK 88,219
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 199K | -38K | 29K | 1 |
| 2018 | - | 123K | 5K | 67K | 1 |
| 2017 | - | 262K | 12K | 61K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
InsilTox ApS has published its annual report for 2018. Gross profit came to DKK 122,884, and the net result was DKK 5,167.
About insilTox ApS
insilTox ApS is a Danish company of the type Anpartsselskab based in Kgs. Lyngby, founded in 2015. The company is registered under the industry Anden teknisk rådgivning. The management consists of Svava Osk Jonsdottir. The company is owned by insilTox Holding ApS. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 158,376 and a net result of DKK 3,502 compared with DKK 3,861 the year before. Equity in the 2025 report amounted to DKK 46,998.